Experience

Aeglea BioTherapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Chief Financial Officer

  • 2023 - Present



Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)

• United States
• Biotechnology Research
• 100 - 200 Employee

• Chief Financial Officer

  • 2021 - 2023

• Vice President Finance

  • 2019 - 2021

  Westlake Village, CA



Shire

• Japan
• Biotechnology Research
• 700 & Above Employee

• Vice President, Investor Relations

  • 2018 - 2019

  Zürich Area, Switzerland Head of International Investor Relations until acquisition of Shire by Takeda



Amgen

• United States
• Biotechnology Research
• 700 & Above Employee

• Investor Relations Director

  • 2014 - 2018

  - Develop proactive and reactive messaging to build investor alignment with company strategy and confidence in management execution, with a focus on financial and commercial affairs. - Craft messages and materials for key investor events including earnings calls, broker conferences, non-deal roadshows, and other investor meetings. - Manage relationships with internal business leaders and sell-side/buy-side analysts

• Director, Corporate Financial Planning and Analysis

  • 2011 - 2014

  - Lead the Corporate Consolidation and Finance Systems groups - Responsible for global financial forecast consolidation, scenario planning, long range planning, earnings calls & guidance, and management reporting - Manage Amgen's Finance planning and reporting tools - Previously led the FP&A teams supporting Amgen's corporate functions (IS, HR, Finance, Legal, Compliance, Gov't Affairs) and partnerships

• Senior Manager, Treasury

  • 2010 - 2011

  - Managed capital planning function, including cash flow and balance sheet forecasting, capital structure planning, M&A analysis, and share repurchase program. - Managed debt capital markets, including debt planning and issuance, and interest rate hedging. - Supported cash flow and balance sheet foreign exchange hedging program

• Senior Manager, Sales & Marketing Financial Planning and Analysis

  • 2007 - 2010

  - Led revenue forecasting process for three oncology biologics. - Managed expense planning for the Oncology Business Unit.

• Manager, Operations Financial Planning and Analysis

  • 2005 - 2007

  - Managed consolidated planning, reporting, and analysis for five manufacturing sites

• Associate Manager, Capital Finance

  • 2003 - 2005

  - Developed business cases, performed financial analyses (NPV, IRR, P&L projections), and created presentations for CFO and EVPs in support of capital project approvals. - Led development of new capital expenditure planning/reporting processes and systems.



Arthur Andersen LLP

• Senior Consultant

  • 1998 - 2002

  Performed valuations, financial analyses, and accounting analyses, and related reports and presentations for clients across diverse industries such as health care, financial services, defense, construction, high tech, entertainment, and real estate.